Annual ROE
-59.99%
-14.64%-32.28%
December 31, 2023
Summary
- As of February 7, 2025, ABUS annual return on equity is -59.99%, with the most recent change of -14.64% (-32.28%) on December 31, 2023.
- During the last 3 years, ABUS annual ROE has risen by +12.98% (+17.79%).
- ABUS annual ROE is now -100.52% below its all-time high of 11.63 thousand%, reached on December 31, 2006.
Performance
ABUS ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-67.36%
-2.81%-4.35%
September 30, 2024
Summary
- As of February 7, 2025, ABUS quarterly return on equity is -67.36%, with the most recent change of -2.81% (-4.35%) on September 30, 2024.
- Over the past year, ABUS quarterly ROE has dropped by -7.24% (-12.04%).
- ABUS quarterly ROE is now -125.10% below its all-time high of 268.38%, reached on December 31, 2012.
Performance
ABUS Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ABUS ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -32.3% | -12.0% |
| 3 y3 years | +17.8% | -49.5% |
| 5 y5 years | -101.2% | -49.5% |
ABUS ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -32.3% | at low | -49.5% | at low |
| 5 y | 5-year | -32.3% | +46.7% | -49.5% | +54.2% |
| alltime | all time | -100.5% | +95.1% | -125.1% | +73.8% |
Arbutus Biopharma ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -67.36%(+4.4%) |
| Jun 2024 | - | -64.55%(+7.4%) |
| Mar 2024 | - | -60.12%(+5.8%) |
| Dec 2023 | -59.99%(+32.3%) | -56.84%(+2.5%) |
| Sep 2023 | - | -55.47%(+8.6%) |
| Jun 2023 | - | -51.06%(+8.7%) |
| Mar 2023 | - | -46.98%(+4.3%) |
| Dec 2022 | -45.35%(-19.3%) | -45.05%(0.0%) |
| Sep 2022 | - | -45.05%(-8.0%) |
| Jun 2022 | - | -48.96%(-11.9%) |
| Mar 2022 | - | -55.58%(-10.1%) |
| Dec 2021 | -56.19%(-23.0%) | -61.84%(-6.4%) |
| Sep 2021 | - | -66.09%(-11.4%) |
| Jun 2021 | - | -74.58%(+1.8%) |
| Mar 2021 | - | -73.27%(-5.6%) |
| Dec 2020 | -72.97%(-35.2%) | -77.58%(-14.7%) |
| Sep 2020 | - | -90.90%(-38.2%) |
| Jun 2020 | - | -146.98%(+17.2%) |
| Mar 2020 | - | -125.44%(+14.6%) |
| Dec 2019 | -112.63%(+277.7%) | -109.44%(+25.5%) |
| Sep 2019 | - | -87.19%(+95.1%) |
| Jun 2019 | - | -44.68%(+51.7%) |
| Mar 2019 | - | -29.46%(+10.3%) |
| Dec 2018 | -29.82%(-31.9%) | -26.70%(-26.0%) |
| Sep 2018 | - | -36.09%(+16.2%) |
| Jun 2018 | - | -31.05%(-29.3%) |
| Mar 2018 | - | -43.93%(-4.5%) |
| Dec 2017 | -43.80%(-57.2%) | -45.99%(-60.3%) |
| Sep 2017 | - | -115.97%(+19.3%) |
| Jun 2017 | - | -97.18%(-10.7%) |
| Mar 2017 | - | -108.80%(+21.0%) |
| Dec 2016 | -102.35%(+418.8%) | -89.90%(+159.5%) |
| Sep 2016 | - | -34.64%(+1.4%) |
| Jun 2016 | - | -34.17%(+189.6%) |
| Mar 2016 | - | -11.80%(-10.7%) |
| Dec 2015 | -19.73%(-62.6%) | -13.22%(-18.2%) |
| Sep 2015 | - | -16.16%(+14.1%) |
| Jun 2015 | - | -14.16%(-14.8%) |
| Mar 2015 | - | -16.62%(-61.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | -52.76%(+87.8%) | -42.83%(-4.0%) |
| Sep 2014 | - | -44.62%(-8.6%) |
| Jun 2014 | - | -48.80%(-11.9%) |
| Mar 2014 | - | -55.37%(+58.9%) |
| Dec 2013 | -28.09%(-121.9%) | -34.84%(-137.2%) |
| Sep 2013 | - | 93.74%(-25.1%) |
| Jun 2013 | - | 125.22%(-27.3%) |
| Mar 2013 | - | 172.33%(-35.8%) |
| Dec 2012 | 128.40%(-201.5%) | 268.38%(-204.6%) |
| Sep 2012 | - | -256.61%(+71.3%) |
| Jun 2012 | - | -149.84%(-4.1%) |
| Mar 2012 | - | -156.31%(+15.7%) |
| Dec 2011 | -126.54%(+64.0%) | -135.12%(+53.5%) |
| Sep 2011 | - | -88.03%(+23.9%) |
| Jun 2011 | - | -71.04%(+28.7%) |
| Mar 2011 | - | -55.18%(+4.8%) |
| Dec 2010 | -77.14%(+175.8%) | -52.65%(+27.9%) |
| Sep 2010 | - | -41.17%(+5.1%) |
| Jun 2010 | - | -39.18%(+23.6%) |
| Mar 2010 | - | -31.71%(+35.7%) |
| Dec 2009 | -27.97%(-32.4%) | -23.37%(+24.6%) |
| Sep 2009 | - | -18.76%(-23.2%) |
| Jun 2009 | - | -24.43%(-28.7%) |
| Mar 2009 | - | -34.24%(+0.5%) |
| Dec 2008 | -41.36%(+48.4%) | -34.07%(+0.1%) |
| Sep 2008 | - | -34.02%(+152.9%) |
| Jun 2008 | - | -13.45%(-31.6%) |
| Mar 2008 | - | -19.65%(+14.0%) |
| Dec 2007 | -27.88%(-100.2%) | -17.24%(-14.1%) |
| Sep 2007 | - | -20.06%(-37.3%) |
| Jun 2007 | - | -32.01% |
| Dec 2006 | 11.63 K%(>+9900.0%) | - |
| Dec 2005 | 43.58%(-103.5%) | - |
| Dec 2004 | -1231.73%(+588.8%) | - |
| Dec 2003 | -178.83%(+133.6%) | - |
| Dec 2002 | -76.54%(+149.9%) | - |
| Dec 2001 | -30.63%(-5.3%) | - |
| Dec 2000 | -32.34%(-18.3%) | - |
| Dec 1999 | -39.57%(-34.8%) | - |
| Dec 1998 | -60.67% | - |
FAQ
- What is Arbutus Biopharma annual return on equity?
- What is the all time high annual ROE for Arbutus Biopharma?
- What is Arbutus Biopharma annual ROE year-on-year change?
- What is Arbutus Biopharma quarterly return on equity?
- What is the all time high quarterly ROE for Arbutus Biopharma?
- What is Arbutus Biopharma quarterly ROE year-on-year change?
What is Arbutus Biopharma annual return on equity?
The current annual ROE of ABUS is -59.99%
What is the all time high annual ROE for Arbutus Biopharma?
Arbutus Biopharma all-time high annual return on equity is 11.63 K%
What is Arbutus Biopharma annual ROE year-on-year change?
Over the past year, ABUS annual return on equity has changed by -14.64% (-32.28%)
What is Arbutus Biopharma quarterly return on equity?
The current quarterly ROE of ABUS is -67.36%
What is the all time high quarterly ROE for Arbutus Biopharma?
Arbutus Biopharma all-time high quarterly return on equity is 268.38%
What is Arbutus Biopharma quarterly ROE year-on-year change?
Over the past year, ABUS quarterly return on equity has changed by -7.24% (-12.04%)